503 related articles for article (PubMed ID: 29769103)
1. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.
van Leeuwen CM; Oei AL; Crezee J; Bel A; Franken NAP; Stalpers LJA; Kok HP
Radiat Oncol; 2018 May; 13(1):96. PubMed ID: 29769103
[TBL] [Abstract][Full Text] [Related]
2. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
Guerrero M; Li XA
Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
[TBL] [Abstract][Full Text] [Related]
3. Obtaining organ-specific radiobiological parameters from clinical data for radiation therapy planning of head and neck cancers.
Quashie EE; Li XA; Prior P; Awan M; Schultz C; Tai A
Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37903437
[No Abstract] [Full Text] [Related]
4. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
[TBL] [Abstract][Full Text] [Related]
5. Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters.
Borst GR; Ishikawa M; Nijkamp J; Hauptmann M; Shirato H; Bengua G; Onimaru R; de Josien Bois A; Lebesque JV; Sonke JJ
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1596-603. PubMed ID: 20231066
[TBL] [Abstract][Full Text] [Related]
6. NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction.
Wennberg BM; Baumann P; Gagliardi G; Nyman J; Drugge N; Hoyer M; Traberg A; Nilsson K; Morhed E; Ekberg L; Wittgren L; Lund JÅ; Levin N; Sederholm C; Lewensohn R; Lax I
Acta Oncol; 2011 May; 50(4):518-27. PubMed ID: 21198416
[TBL] [Abstract][Full Text] [Related]
7. Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy.
Cui M; Gao XS; Li X; Ma M; Qi X; Shibamoto Y
Radiat Oncol; 2022 Mar; 17(1):54. PubMed ID: 35303922
[TBL] [Abstract][Full Text] [Related]
8. The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy.
Wheldon TE; Deehan C; Wheldon EG; Barrett A
Radiother Oncol; 1998 Mar; 46(3):285-95. PubMed ID: 9572622
[TBL] [Abstract][Full Text] [Related]
9. A LQ-based kinetic model formulation for exploring dynamics of treatment response of tumours in patients.
Scheidegger S; Lutters G; Bodis S
Z Med Phys; 2011 Sep; 21(3):164-73. PubMed ID: 21237624
[TBL] [Abstract][Full Text] [Related]
10. Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects.
Hoffmann AL; den Hertog D; Siem AY; Kaanders JH; Huizenga H
Phys Med Biol; 2008 Nov; 53(22):6345-62. PubMed ID: 18941280
[TBL] [Abstract][Full Text] [Related]
11. A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity.
Roberts SA; Hendry JH
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):689-99. PubMed ID: 9635721
[TBL] [Abstract][Full Text] [Related]
12. On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model.
Unkel S; Belka C; Lauber K
Radiat Oncol; 2016 Jan; 11():11. PubMed ID: 26822015
[TBL] [Abstract][Full Text] [Related]
13. The impact of fractionation in SBRT: analysis with the linear quadratic model and the universal survival curve model.
Wennberg B; Lax I
Acta Oncol; 2013 Jun; 52(5):902-9. PubMed ID: 23327339
[TBL] [Abstract][Full Text] [Related]
14. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
Xiong W; Li J; Ma CM
Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
[TBL] [Abstract][Full Text] [Related]
15. Comparison of fractionation schedules in the large heterogeneity limit.
Guerrero M
Med Phys; 2009 Apr; 36(4):1384-8. PubMed ID: 19472645
[TBL] [Abstract][Full Text] [Related]
16. Dose escalation to combat hypoxia in prostate cancer: a radiobiological study on clinical data.
Wang JZ; Li XA; Mayr NA
Br J Radiol; 2006 Nov; 79(947):905-11. PubMed ID: 16885177
[TBL] [Abstract][Full Text] [Related]
17. SU-E-T-02: Radiobiological Comparison of Two Treatment Schemas in IMRT Prostate Radiotherapy.
Hernández TG; González AV; Cabañero DG; González LB; Ferrando JR; Peidro JP; Torrecilla JL
Med Phys; 2012 Jun; 39(6Part9):3702. PubMed ID: 28519019
[TBL] [Abstract][Full Text] [Related]
18. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
[TBL] [Abstract][Full Text] [Related]
19. The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy.
Jones B; Dale RG
Br J Radiol; 2005 Oct; 78(934):939-44. PubMed ID: 16177018
[TBL] [Abstract][Full Text] [Related]
20. Effect of heterogeneity in radiosensitivity on LQ based isoeffect formalism for low alpha/beta cancers.
Moiseenko V
Acta Oncol; 2004; 43(5):499-502. PubMed ID: 15360056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
